Creative Medical Technology Holdings Inc (CELZ)

[MeatSlice]

Dont forget the POLITICO article just published mentioning CELZ out of all possible companies in the market.

Heres the excerpt:

STEM CELL COMPANY LOOKING TO USE RIGHT-TO-TRY — Creative Medical Technologies, a biotech focusing on stem cell treatments, is looking to offer its experimental treatment AmnioStem to cancer patients once Phase I clinical trials are complete. The company “will be well positioned to allow access to end stage cancer patients under the Right-to-Try law,” Chief Scientific Officer Thomas Ichim said in a statement. It’s testing AmnioStem to treat cancer-associated wasting, or cachexia. If the product turns out to be successful, CEO Timothy Warrington said it could buy cancer patients time to wait for new therapies to become available.

The company didn’t respond to requests for more information on how it would implement its program, such as how if it would be able to afford to help all patients who request the treatment or whether and how much it would charge. But it will be interesting to watch how this company — or any biotech — navigates the new law S. 204 (115), which lets patients skirt the FDA when requesting access to experimental medicines.